Company Search:
Advanced Search
Sponsored Links
Karo Pharma AB Company Snapshot
Karo Pharma AB operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Karo Pharma AB with three other companies in this sector in Sweden: Medivir AB (2016 sales of 93.04 million Swedish Kronor [US$10.94 million] of which 100% was Pharmaceutical), Bioinvent International AB (71.28 million Swedish Kronor [US$8.38 million] of which 100% was Drug Development), and Saniona AB (74.92 million Swedish Kronor [US$8.81 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Karo Pharma AB
  Stock Performance Chart for Karo Pharma AB
  Stock Data: Recent Stock Performance:
  Current Price (12/8/2017): 34.62
(Figures in Swedish Kronor)
1 Week -4.9%   13 Weeks 0.3%  
4 Weeks -4.7%   52 Weeks 37.7%  
Karo Pharma AB Key Data:
  Ticker: KARO Country: Sweden
  Exchanges: STO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 347,261,000
(Year Ending Jan 2017).
Employees: 69
  Currency: Swedish Kronor Market Cap: 3,007,275,600
  Fiscal Yr Ends: December Shares Outstanding: 86,861,195
  Share Type: Fri Aktie Closely Held Shares: 15,113,206
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.